TWST
Twist Bioscience Corp
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$138.74
−1.11%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 16.76x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 20.64x
- Price / sales
- 21.30x
- Price / cash flow
- -173.32x
Enterprise value
- Enterprise value
- $9.1B
- EV / sales
- 21.13x
- EV / EBITDA
- -84.66x
- EV / EBIT
- -66.23x
- Market cap
- $9.2B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026